Legal & General Group Plc - CARIBOU BIOSCIENCES INC ownership

CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 2 filers reported holding CARIBOU BIOSCIENCES INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of CARIBOU BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$29,607
+26.4%
6,194
+12.4%
0.00%
Q2 2023$23,418
-43.2%
5,510
-29.0%
0.00%
Q1 2023$41,200
-63.9%
7,759
-57.4%
0.00%
Q4 2022$114,271
-39.2%
18,196
+2.4%
0.00%
Q3 2022$188,000
+111.2%
17,767
+7.9%
0.00%
Q2 2022$89,000
-13.6%
16,473
+46.6%
0.00%
Q1 2022$103,000
-16.3%
11,233
+37.8%
0.00%
Q4 2021$123,000
+186.0%
8,153
+353.4%
0.00%
Q3 2021$43,0001,7980.00%
Other shareholders
CARIBOU BIOSCIENCES INC shareholders Q4 2023
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 474,067$2,014,78515.70%
Memorial Sloan Kettering Cancer Center 544,196$2,312,8337.30%
Elmwood Wealth Management, Inc. 2,364,415$10,048,7644.68%
PFM Health Sciences, LP 5,570,869$23,676,1930.92%
Avidity Partners Management LP 2,758,600$11,724,0500.41%
Green Alpha Advisors, LLC 105,826$449,7600.30%
Bruce & Co., Inc. 200,000$850,0000.24%
SVB FINANCIAL GROUP 20,714$88,0350.17%
Rokos Capital Management LLP 2,748,139$11,202,7890.11%
Tekla Capital Management LLC 567,147$2,410,3750.09%
View complete list of CARIBOU BIOSCIENCES INC shareholders